Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors

Complete Title: ALTE03N1, Key Adverse Events after Childhood Cancer
Trial Phase: N/A
Investigator: K. Scott Baker

This clinical trial studies cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer. A patient's genes may affect the risk of developing complications, such as congestive heart failure, heart attack, stroke, and second cancer, years after undergoing cancer treatment. Genetic studies may help doctors identify survivors of childhood cancer who are more likely to develop late complications.

Keywords:
  • Hematologic Malignancies
  • Pediatric Cancers, Miscellaneous
  • Solid Tumors
  • Neoplasms
  • Cardiovascular Diseases
  • Cancer Survivor
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
Pediatric
N/A
K. Scott Baker
ALTE03N1
NCT00082745
ALTE03N1, Key Adverse Events after Childhood Cancer
Hematologic Malignancies
Pediatric Cancers, Miscellaneous
Solid Tumors
Neoplasms
Cardiovascular Diseases
Cancer Survivor